Preclinical studies and drug combination of low-cost molecules for Chagas disease

Chagas disease is caused by the protozoan Trypanosoma cruzi (T. cruzi). It remains the major parasitic disease in Latin America and is spreading worldwide, affecting over 10 million people. Hundreds of new compounds with trypanosomicidal action have been identified from different sources such as syn...

Popoln opis

Bibliografske podrobnosti

Glavni avtor:	Aguilera, Elena (author)
Drugi avtorji:	Sánchez, Carina (author), Cruces, María Eugenia (author), Dávila Saralegui, Belén (author), Minini Rivas, Lucía (author), Mosquillo, María Florencia (author), Pérez-Díaz, Leticia (author), Serna, Elva (author), Torres, Susana (author), Schini, Alicia (author), Sanabria, Luis (author), Vera de Bilbao, N.I. (author), Yaluff, Gloria (author), Zolessi, Flavio R. (author), Ceilas, Luis Fabian (author), Cerecetto, Hugo (author), Álvarez, Guzmán (author)
Format:	article
Jezik:	angleščina
Izdano:	2023
Teme:	Chagas disease Pre-clinically studied Drug combination RMN metabolomics
Online dostop:	https://hdl.handle.net/20.500.12008/43097
Oznake:	Označite Brez oznak, prvi označite!